A new clinical trial, presented at Alzheimer’s Association International Conference® (AAIC®), has many feeling hopeful, especially for the Loveless couple.
John Loveless and his wife, Jennifer, live in Sugarcreek Twp. In January 2017, John was diagnosed with Alzheimer’s disease and has been on a clinical trial where he travels once a month to Columbus. With news of a new drug that could potentially treat Alzheimer’s, John & Jennifer Loveless are feeling better about the future.
Since the diagnosis, the couple has been helping with the Alzheimer’s Association Miami Valley Chapter in raising awareness and money for research. “It’s more than just a lifeline, it is a connection with other people who are struggling with this devastating disease,” Jennifer Loveless said.
The Loveless couple has been featured on several local media outlets sharing their clinical trial experience, latest BAN2401 drug trial and why they Walk to End Alzheimers’®.
Go here to view broadcast about BAN2401 drug trial, the Loveless and Eric VanVlymen’s interview. Go here for clinical trial and Walk to End Alzheimer’s segment.
Six new studies revealed at AAIC® 2018
The Alzheimer’s Association International Conference® (AAIC®) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment, and improvements in diagnosis for Alzheimer’s disease. Research presented at AAIC® 2018 focused on prevention, risk reduction, treating non-cognitive symptoms of dementia and more.
Here are the latest research studies presented at AAIC® 2018. (go here for highlights of each study).
- New Alzheimer’s/dementia clinical trial results offer hope — SPRINT MIND trial
- Link between pregnancy, reproductive history and dementia risk in women
- First dementia prevalence data in LGB older adults
- Preliminary successes treating non-cognitive symptoms of dementia
- Gut bacteria and lipid metabolism may influence Alzheimer’s and other brain diseases
- BAN2401 phase II data released
- New guidelines for clinical diagnosis of Alzheimer’s and other dementias
To be part of this year’s Walk to End Alzheimer’s, go to http://www.alz.org/walk to find a local walk near you.
alzdayton.wordpress.com 